Article Details

US FDA narrows patient group for Biogen's Alzheimer's drug

Retrieved on: 2021-07-08 11:49:57

Tags for this article:

Click the tags to see associated articles and topics

US FDA narrows patient group for Biogen's Alzheimer's drug. View article details on hiswai:

Excerpt

The new patient population is largely in-line with how the drug was expected to be used, Truist Securities analyst Robyn Karnauskas said in a note.

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up